To compare the anaesthetic and analgesic efficacy of plain ropivacaine with ropivacaine and dexmedetomidine in patients of manipur undergoing lower limb surgeries using ultrasound guided combined femoral and sciatic nerve block as a randomised clinical trial

Comparative evaluation of half percent Ropivacaine with ropivacaine half percent and Dexmedetomidine in Ultrasound guided combined Femoral and Sciatic nerve block for lower limb surgeries. A Randomized clinical study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069383

Enrollment

Registered

2024-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj. Ropivacaine 0.5% and Inj. Dexmedetomidine 25 mcg.: Study participants will be randomized into two groups. Group B patients will receive 40 ml of drug solution containing Ropivacain

Eligibility

Inclusion criteria

Inclusion criteria: Sex: Either sex Age: 18 to 65 years ASA Grade I or II patients scheduled for elective lower limb surgeries

Exclusion criteria

Exclusion criteria: 1.Uncooperative patients / unwilling patients 2.Hypersensitivity to amide group of Local anaesthetic agents and dexmedetomidine 3.Patients having hypertension / diabetes mellitus / neuropathy / peripheral nerve injury 4.Pregnancy and lactation 5.Patient on anticoagulants or bleeding disorder 6.Local site infection

Design outcomes

Primary

Measure	Time frame
To compare the Anaesthetic and analgesic efficacy of the two drug combinations used in the study.Timepoint: Outcome will be assessed during the intraoperative and postoperative period from the time of onset of sensory and motor blockade till the time of first rescue analgesia.	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr.Longjam Eshori

REGIONAL INSTITUTE OF MEDICAL SCIENCES, IMPHAL

drlongjam@gmail.com9436036407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026